The "Antimicrobial Technologies for Enhanced Consumer Health" report has been added to ResearchAndMarkets.com's offering.

Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections.

While metallic ions continue to be one of the most potent antimicrobial technology platform, several new innovations across antimicrobial polymers, peptides and naturally sourced agents will lead the global consumer health landscape.

Key opportunities for antimicrobial technologies will depend on the use of optimal combination of multiple microbicidal platforms for several consumer health applications.

Key Topics Covered:

1. Executive Summary

2. Technology Overview

3. Key Research, Regional, and IP Trends

4. Overview of Stakeholder Initiatives

5. Future Perspectives

6. Growth Opportunities and Companies to Action

7. Appendix

Companies Mentioned

  • Allvivo Vascular Inc., US
  • Chamgonano, China
  • Pertinax Pharma Limited, UK

For more information about this report visit https://www.researchandmarkets.com/research/dvk29q/2017?w=4